Center for Perioperative Optimization, Department of Surgery, Herlev Hospital, University of Copenhagen, Borgmester Ib Juuls Vej 1, DK-2730, Herlev, Denmark.
Center for Perioperative Optimization, Department of Surgery, Herlev Hospital, University of Copenhagen, Borgmester Ib Juuls Vej 1, DK-2730, Herlev, Denmark.
Int J Surg. 2022 Sep;105:106841. doi: 10.1016/j.ijsu.2022.106841. Epub 2022 Aug 25.
Long-term outcomes of cholecystectomy are largely unknown though it is a common procedure in general surgery. We aimed to investigate the long-term mortality rate and incidence of intestinal obstruction after laparoscopic cholecystectomy.
This systematic review and meta-analysis was reported according to the PRISMA 2020 and AMSTAR guidelines. A protocol was registered on PROSPERO (CRD42020178906). The databases PubMed, EMBASE, and Cochrane CENTRAL were last searched on February 9, 2022 for original studies on long-term complications with n > 40 and follow-up ≥ 6 months. Outcomes were long-term mortality and incidence of intestinal obstruction, and meta-analyses were conducted. Risk of bias was assessed with Newcastle-Ottawa Scale and Cochrane "Risk of bias"-tool according to study design.
We included 41 studies that reported long-term follow-up on 1,000,534 patients. Of these, 38 studies reported on mortality (514,242 patients) that ranged from 0 to 32%. Meta-analysis estimated a long-term mortality rate of 2.0% (95% CI 1.7-2.3%) after laparoscopic cholecystectomy. Five studies including 486,292 patients reported on intestinal obstruction that ranged from 0 to 6%. Meta-analysis estimated a long-term rate of intestinal obstruction of 1.3% (95% CI 0.8-1.8%).
Long-term mortality after laparoscopic cholecystectomy was 2%. The incidence of long-term intestinal obstruction after laparoscopic cholecystectomy was 1.3%.
尽管胆囊切除术在普通外科中是一种常见的手术,但长期的手术效果却知之甚少。本研究旨在调查腹腔镜胆囊切除术后的长期死亡率和肠梗阻发生率。
本系统评价和荟萃分析根据 PRISMA 2020 和 AMSTAR 指南进行报告。该方案已在 PROSPERO(CRD42020178906)上注册。于 2022 年 2 月 9 日最后检索了 PubMed、EMBASE 和 Cochrane CENTRAL 数据库,以获取 n>40 例且随访时间≥6 个月的长期并发症的原始研究。研究结局为长期死亡率和肠梗阻发生率,并进行荟萃分析。根据研究设计,采用纽卡斯尔-渥太华量表和 Cochrane“偏倚风险”-工具评估偏倚风险。
共纳入 41 项研究,这些研究报告了 1000534 例患者的长期随访结果。其中,38 项研究报告了死亡率(514242 例患者),范围为 0 至 32%。荟萃分析估计腹腔镜胆囊切除术后的长期死亡率为 2.0%(95%CI 1.7-2.3%)。5 项研究(486292 例患者)报告了肠梗阻,范围为 0 至 6%。荟萃分析估计腹腔镜胆囊切除术后长期肠梗阻的发生率为 1.3%(95%CI 0.8-1.8%)。
腹腔镜胆囊切除术后的长期死亡率为 2%。腹腔镜胆囊切除术后长期肠梗阻的发生率为 1.3%。